| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4754674
Max Phase: Preclinical
Molecular Formula: C13H13NO4
Molecular Weight: 247.25
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Oc1ccc(CNc2ccc(O)c(O)c2)cc1O
Standard InChI: InChI=1S/C13H13NO4/c15-10-3-1-8(5-12(10)17)7-14-9-2-4-11(16)13(18)6-9/h1-6,14-18H,7H2
Standard InChI Key: BOLQVOXQHFRJPR-UHFFFAOYSA-N
Associated Targets(Human)
Arginase-1 360 Activities
Associated Targets(non-human)
Arginase-1 70 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 247.25 | Molecular Weight (Monoisotopic): 247.0845 | AlogP: 2.12 | #Rotatable Bonds: 3 |
| Polar Surface Area: 92.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.13 | CX Basic pKa: 4.92 | CX LogP: 1.96 | CX LogD: 1.95 |
| Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.42 | Np Likeness Score: -0.20 |
References
| 1. Muller, J., Cardey, B., Zedet, A., Desingle, C., Grzybowski, M., Pomper, P., Foley, S., Harakat, D., Ramseyer, C., Girard, C., Pudlo, M.. (2020) Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors, 11 (5): [PMID:33479657] [10.1039/d0md00011f] |
Source
Source(1):